APO Research
Talk to an analyst

APO RESEARCH · REPORT

Transdermal Patch for Pain Relief

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Transdermal Patch for Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchTransdermal Patch for Pain Relief Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Transdermal Patch for Pain Relief Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Transdermal Patch for Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Transdermal Patch for Pain Relief Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Transdermal Patch for Pain Relief Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Transdermal Patch for Pain Relief market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Transdermal Patch for Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Transdermal Patch for Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Transdermal Patch for Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Transdermal Patch for Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Transdermal Patch for Pain Relief include Teva, Sanofi, Johnson & Johnson, Pfizer, GSK, Viatris, Qizheng, Performance Health and Nichiban, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Transdermal Patch for Pain Relief market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transdermal Patch for Pain Relief and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transdermal Patch for Pain Relief sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transdermal Patch for Pain Relief market size, projected growth trends, production technologies, key applications, and end-use industries.

Transdermal Patch for Pain Relief Segment by Company

Teva

Sanofi

Johnson & Johnson

Pfizer

GSK

Viatris

Qizheng

Performance Health

Nichiban

Lingrui

Laboratoires Genevrier

IBSA Group

Huarun 999

Hisamitsu

Haw Par

Endo

BLUE-EMU

Transdermal Patch for Pain Relief Segment by Type

Peppermint Patch

Fentanyl Patch

Capsaicin Patch

Lidocaine Patch

Diclofenac Patch

Methyl Salicylate Patch

Indomethacin Patch

Other

Transdermal Patch for Pain Relief Segment by Application

OTC

Rx

Transdermal Patch for Pain Relief Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Patch for Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transdermal Patch for Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Patch for Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transdermal Patch for Pain Relief market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Transdermal Patch for Pain Relief manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Transdermal Patch for Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Transdermal Patch for Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Transdermal Patch for Pain Relief Industry Trends Table 2. Transdermal Patch for Pain Relief Industry Drivers Table 3. Transdermal Patch for Pain Relief Industry Opportunities and Challenges Table 4. Transdermal Patch for Pain Relief Industry Restraints Table 5. Global Transdermal Patch for Pain Relief Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Transdermal Patch for Pain Relief Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Transdermal Patch for Pain Relief Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Transdermal Patch for Pain Relief Sales Market Share by Manufacturers Table 9. Global Transdermal Patch for Pain Relief Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Transdermal Patch for Pain Relief Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Transdermal Patch for Pain Relief Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Transdermal Patch for Pain Relief Manufacturers, Product Type & Application Table 13. Global Transdermal Patch for Pain Relief Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Transdermal Patch for Pain Relief by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Peppermint Patch Table 17. Major Manufacturers of Fentanyl Patch Table 18. Major Manufacturers of Capsaicin Patch Table 19. Major Manufacturers of Lidocaine Patch Table 20. Major Manufacturers of Diclofenac Patch Table 21. Major Manufacturers of Methyl Salicylate Patch Table 22. Major Manufacturers of Indomethacin Patch Table 23. Major Manufacturers of Other Table 24. Global Transdermal Patch for Pain Relief Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Transdermal Patch for Pain Relief Sales by Type (2021-2026) & (K Units) Table 26. Global Transdermal Patch for Pain Relief Sales by Type (2027-2032) & (K Units) Table 27. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2026) Table 28. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2027-2032) Table 29. Global Transdermal Patch for Pain Relief Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 30. Global Transdermal Patch for Pain Relief Revenue by Type (2021-2026) & (K Units) Table 31. Global Transdermal Patch for Pain Relief Revenue by Type (2027-2032) & (K Units) Table 32. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2026) Table 33. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2027-2032) Table 34. Major Manufacturers of OTC Table 35. Major Manufacturers of Rx Table 36. Global Transdermal Patch for Pain Relief Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Transdermal Patch for Pain Relief Sales by Application (2021-2026) & (K Units) Table 38. Global Transdermal Patch for Pain Relief Sales by Application (2027-2032) & (K Units) Table 39. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2026) Table 40. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2027-2032) Table 41. Global Transdermal Patch for Pain Relief Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Transdermal Patch for Pain Relief Revenue by Application (2021-2026) & (K Units) Table 43. Global Transdermal Patch for Pain Relief Revenue by Application (2027-2032) & (K Units) Table 44. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2026) Table 45. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2027-2032) Table 46. Global Transdermal Patch for Pain Relief Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Transdermal Patch for Pain Relief Sales by Region (2021-2026) & (K Units) Table 48. Global Transdermal Patch for Pain Relief Sales Market Share by Region (2021-2026) Table 49. Global Transdermal Patch for Pain Relief Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Transdermal Patch for Pain Relief Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 53. North America Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 54. Europe Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 56. Europe Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2027-2032) & (K Units) Table 63. Global Transdermal Patch for Pain Relief Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Transdermal Patch for Pain Relief Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Transdermal Patch for Pain Relief Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Transdermal Patch for Pain Relief Revenue Market Share by Region (2021-2026) Table 67. Global Transdermal Patch for Pain Relief Revenue Market Share by Region (2027-2032) Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Transdermal Patch for Pain Relief Product Portfolio Table 72. Teva Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Transdermal Patch for Pain Relief Product Portfolio Table 77. Sanofi Recent Development Table 78. Johnson & Johnson Company Information Table 79. Johnson & Johnson Business Overview Table 80. Johnson & Johnson Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Johnson & Johnson Transdermal Patch for Pain Relief Product Portfolio Table 82. Johnson & Johnson Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Transdermal Patch for Pain Relief Product Portfolio Table 87. Pfizer Recent Development Table 88. GSK Company Information Table 89. GSK Business Overview Table 90. GSK Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. GSK Transdermal Patch for Pain Relief Product Portfolio Table 92. GSK Recent Development Table 93. Viatris Company Information Table 94. Viatris Business Overview Table 95. Viatris Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Viatris Transdermal Patch for Pain Relief Product Portfolio Table 97. Viatris Recent Development Table 98. Qizheng Company Information Table 99. Qizheng Business Overview Table 100. Qizheng Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Qizheng Transdermal Patch for Pain Relief Product Portfolio Table 102. Qizheng Recent Development Table 103. Performance Health Company Information Table 104. Performance Health Business Overview Table 105. Performance Health Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Performance Health Transdermal Patch for Pain Relief Product Portfolio Table 107. Performance Health Recent Development Table 108. Nichiban Company Information Table 109. Nichiban Business Overview Table 110. Nichiban Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Nichiban Transdermal Patch for Pain Relief Product Portfolio Table 112. Nichiban Recent Development Table 113. Lingrui Company Information Table 114. Lingrui Business Overview Table 115. Lingrui Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Lingrui Transdermal Patch for Pain Relief Product Portfolio Table 117. Lingrui Recent Development Table 118. Laboratoires Genevrier Company Information Table 119. Laboratoires Genevrier Business Overview Table 120. Laboratoires Genevrier Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Laboratoires Genevrier Transdermal Patch for Pain Relief Product Portfolio Table 122. Laboratoires Genevrier Recent Development Table 123. IBSA Group Company Information Table 124. IBSA Group Business Overview Table 125. IBSA Group Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. IBSA Group Transdermal Patch for Pain Relief Product Portfolio Table 127. IBSA Group Recent Development Table 128. Huarun 999 Company Information Table 129. Huarun 999 Business Overview Table 130. Huarun 999 Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Huarun 999 Transdermal Patch for Pain Relief Product Portfolio Table 132. Huarun 999 Recent Development Table 133. Hisamitsu Company Information Table 134. Hisamitsu Business Overview Table 135. Hisamitsu Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Hisamitsu Transdermal Patch for Pain Relief Product Portfolio Table 137. Hisamitsu Recent Development Table 138. Haw Par Company Information Table 139. Haw Par Business Overview Table 140. Haw Par Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Haw Par Transdermal Patch for Pain Relief Product Portfolio Table 142. Haw Par Recent Development Table 143. Endo Company Information Table 144. Endo Business Overview Table 145. Endo Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Endo Transdermal Patch for Pain Relief Product Portfolio Table 147. Endo Recent Development Table 148. BLUE-EMU Company Information Table 149. BLUE-EMU Business Overview Table 150. BLUE-EMU Transdermal Patch for Pain Relief Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. BLUE-EMU Transdermal Patch for Pain Relief Product Portfolio Table 152. BLUE-EMU Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Transdermal Patch for Pain Relief Distributors List Table 156. Transdermal Patch for Pain Relief Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Transdermal Patch for Pain Relief Product Image Figure 2. Global Transdermal Patch for Pain Relief Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transdermal Patch for Pain Relief Market Size (2021-2032) & (US$ Million) Figure 4. Global Transdermal Patch for Pain Relief Sales (2021-2032) & (K Units) Figure 5. Global Transdermal Patch for Pain Relief Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Transdermal Patch for Pain Relief Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Peppermint Patch Image Figure 9. Fentanyl Patch Image Figure 10. Capsaicin Patch Image Figure 11. Lidocaine Patch Image Figure 12. Diclofenac Patch Image Figure 13. Methyl Salicylate Patch Image Figure 14. Indomethacin Patch Image Figure 15. Other Image Figure 16. Global Transdermal Patch for Pain Relief Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Transdermal Patch for Pain Relief Sales Market Share 2021 VS 2025 VS 2032 Figure 18. Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2032) Figure 19. Global Transdermal Patch for Pain Relief Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Transdermal Patch for Pain Relief Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2032) Figure 22. OTC Image Figure 23. Rx Image Figure 24. Global Transdermal Patch for Pain Relief Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Transdermal Patch for Pain Relief Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2032) Figure 27. Global Transdermal Patch for Pain Relief Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Transdermal Patch for Pain Relief Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2032) Figure 30. North America Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 32. U.S. Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 37. Germany Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 44. China Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Transdermal Patch for Pain Relief Sales Market Share by Country (2021-2032) Figure 52. Brazil Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Transdermal Patch for Pain Relief Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Transdermal Patch for Pain Relief Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Transdermal Patch for Pain Relief Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Transdermal Patch for Pain Relief Revenue (2021-2032) & (US$ Million) Figure 63. North America Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Transdermal Patch for Pain Relief Revenue (2021-2032) & (US$ Million) Figure 65. Europe Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Transdermal Patch for Pain Relief Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Transdermal Patch for Pain Relief Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Transdermal Patch for Pain Relief Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Transdermal Patch for Pain Relief Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Peppermint Patch
  • Fentanyl Patch
  • Capsaicin Patch
  • Lidocaine Patch
  • Diclofenac Patch
  • Methyl Salicylate Patch
  • Indomethacin Patch
  • Other
Applications
  • OTC
  • Rx
Companies covered
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Pfizer
  • GSK
  • Viatris
  • Qizheng
  • Performance Health
  • Nichiban
  • Lingrui
  • Laboratoires Genevrier
  • IBSA Group
  • Huarun 999
  • Hisamitsu
  • Haw Par
  • Endo
  • BLUE-EMU

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Transdermal Patch for Pain Relief Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Transdermal Patch for Pain Relief Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Transdermal Patch for Pain Relief Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Transdermal Patch for Pain Relief Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Transdermal Patch for Pain Relief Market Dynamics
  1. 2.1 Transdermal Patch for Pain Relief Industry Trends
  2. 2.2 Transdermal Patch for Pain Relief Industry Drivers
  3. 2.3 Transdermal Patch for Pain Relief Industry Opportunities and Challenges
  4. 2.4 Transdermal Patch for Pain Relief Industry Restraints
3 Transdermal Patch for Pain Relief Market by Manufacturers
  1. 3.1 Global Transdermal Patch for Pain Relief Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Transdermal Patch for Pain Relief Sales by Manufacturers (2021-2026)
  3. 3.3 Global Transdermal Patch for Pain Relief Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Transdermal Patch for Pain Relief Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Transdermal Patch for Pain Relief Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Transdermal Patch for Pain Relief Manufacturers, Product Type & Application
  7. 3.7 Global Transdermal Patch for Pain Relief Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Transdermal Patch for Pain Relief Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Transdermal Patch for Pain Relief Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Transdermal Patch for Pain Relief Tier 1, Tier 2, and Tier 3
4 Transdermal Patch for Pain Relief Market by Type
  1. 4.1 Transdermal Patch for Pain Relief Type Introduction
  2. 4.1.1 Peppermint Patch
  3. 4.1.2 Fentanyl Patch
  4. 4.1.3 Capsaicin Patch
  5. 4.1.4 Lidocaine Patch
  6. 4.1.5 Diclofenac Patch
  7. 4.1.6 Methyl Salicylate Patch
  8. 4.1.7 Indomethacin Patch
  9. 4.1.8 Other
  10. 4.2 Global Transdermal Patch for Pain Relief Sales by Type
  11. 4.2.1 Global Transdermal Patch for Pain Relief Sales by Type (2021 VS 2025 VS 2032)
  12. 4.2.2 Global Transdermal Patch for Pain Relief Sales by Type (2021-2032)
  13. 4.2.3 Global Transdermal Patch for Pain Relief Sales Market Share by Type (2021-2032)
  14. 4.3 Global Transdermal Patch for Pain Relief Revenue by Type
  15. 4.3.1 Global Transdermal Patch for Pain Relief Revenue by Type (2021 VS 2025 VS 2032)
  16. 4.3.2 Global Transdermal Patch for Pain Relief Revenue by Type (2021-2032)
  17. 4.3.3 Global Transdermal Patch for Pain Relief Revenue Market Share by Type (2021-2032)
5 Transdermal Patch for Pain Relief Market by Application
  1. 5.1 Transdermal Patch for Pain Relief Application Introduction
  2. 5.1.1 OTC
  3. 5.1.2 Rx
  4. 5.2 Global Transdermal Patch for Pain Relief Sales by Application
  5. 5.2.1 Global Transdermal Patch for Pain Relief Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Transdermal Patch for Pain Relief Sales by Application (2021-2032)
  7. 5.2.3 Global Transdermal Patch for Pain Relief Sales Market Share by Application (2021-2032)
  8. 5.3 Global Transdermal Patch for Pain Relief Revenue by Application
  9. 5.3.1 Global Transdermal Patch for Pain Relief Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Transdermal Patch for Pain Relief Revenue by Application (2021-2032)
  11. 5.3.3 Global Transdermal Patch for Pain Relief Revenue Market Share by Application (2021-2032)
6 Global Transdermal Patch for Pain Relief Sales by Region
  1. 6.1 Global Transdermal Patch for Pain Relief Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transdermal Patch for Pain Relief Sales by Region (2021-2032)
  3. 6.2.1 Global Transdermal Patch for Pain Relief Sales by Region (2021-2026)
  4. 6.2.2 Global Transdermal Patch for Pain Relief Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Transdermal Patch for Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Transdermal Patch for Pain Relief Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Transdermal Patch for Pain Relief Revenue by Region
  1. 7.1 Global Transdermal Patch for Pain Relief Revenue by Region
  2. 7.1.1 Global Transdermal Patch for Pain Relief Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Transdermal Patch for Pain Relief Revenue by Region (2021-2026)
  4. 7.1.3 Global Transdermal Patch for Pain Relief Revenue by Region (2027-2032)
  5. 7.1.4 Global Transdermal Patch for Pain Relief Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Transdermal Patch for Pain Relief Revenue (2021-2032)
  8. 7.2.2 North America Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Transdermal Patch for Pain Relief Revenue (2021-2032)
  11. 7.3.2 Europe Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Transdermal Patch for Pain Relief Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Transdermal Patch for Pain Relief Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Transdermal Patch for Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Transdermal Patch for Pain Relief Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Transdermal Patch for Pain Relief Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Transdermal Patch for Pain Relief Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Transdermal Patch for Pain Relief Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK Transdermal Patch for Pain Relief Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Viatris
  32. 8.6.1 Viatris Company Information
  33. 8.6.2 Viatris Business Overview
  34. 8.6.3 Viatris Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Viatris Transdermal Patch for Pain Relief Product Portfolio
  36. 8.6.5 Viatris Recent Developments
  37. 8.7 Qizheng
  38. 8.7.1 Qizheng Company Information
  39. 8.7.2 Qizheng Business Overview
  40. 8.7.3 Qizheng Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Qizheng Transdermal Patch for Pain Relief Product Portfolio
  42. 8.7.5 Qizheng Recent Developments
  43. 8.8 Performance Health
  44. 8.8.1 Performance Health Company Information
  45. 8.8.2 Performance Health Business Overview
  46. 8.8.3 Performance Health Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Performance Health Transdermal Patch for Pain Relief Product Portfolio
  48. 8.8.5 Performance Health Recent Developments
  49. 8.9 Nichiban
  50. 8.9.1 Nichiban Company Information
  51. 8.9.2 Nichiban Business Overview
  52. 8.9.3 Nichiban Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Nichiban Transdermal Patch for Pain Relief Product Portfolio
  54. 8.9.5 Nichiban Recent Developments
  55. 8.10 Lingrui
  56. 8.10.1 Lingrui Company Information
  57. 8.10.2 Lingrui Business Overview
  58. 8.10.3 Lingrui Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lingrui Transdermal Patch for Pain Relief Product Portfolio
  60. 8.10.5 Lingrui Recent Developments
  61. 8.11 Laboratoires Genevrier
  62. 8.11.1 Laboratoires Genevrier Company Information
  63. 8.11.2 Laboratoires Genevrier Business Overview
  64. 8.11.3 Laboratoires Genevrier Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Laboratoires Genevrier Transdermal Patch for Pain Relief Product Portfolio
  66. 8.11.5 Laboratoires Genevrier Recent Developments
  67. 8.12 IBSA Group
  68. 8.12.1 IBSA Group Company Information
  69. 8.12.2 IBSA Group Business Overview
  70. 8.12.3 IBSA Group Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IBSA Group Transdermal Patch for Pain Relief Product Portfolio
  72. 8.12.5 IBSA Group Recent Developments
  73. 8.13 Huarun 999
  74. 8.13.1 Huarun 999 Company Information
  75. 8.13.2 Huarun 999 Business Overview
  76. 8.13.3 Huarun 999 Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Huarun 999 Transdermal Patch for Pain Relief Product Portfolio
  78. 8.13.5 Huarun 999 Recent Developments
  79. 8.14 Hisamitsu
  80. 8.14.1 Hisamitsu Company Information
  81. 8.14.2 Hisamitsu Business Overview
  82. 8.14.3 Hisamitsu Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hisamitsu Transdermal Patch for Pain Relief Product Portfolio
  84. 8.14.5 Hisamitsu Recent Developments
  85. 8.15 Haw Par
  86. 8.15.1 Haw Par Company Information
  87. 8.15.2 Haw Par Business Overview
  88. 8.15.3 Haw Par Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Haw Par Transdermal Patch for Pain Relief Product Portfolio
  90. 8.15.5 Haw Par Recent Developments
  91. 8.16 Endo
  92. 8.16.1 Endo Company Information
  93. 8.16.2 Endo Business Overview
  94. 8.16.3 Endo Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Endo Transdermal Patch for Pain Relief Product Portfolio
  96. 8.16.5 Endo Recent Developments
  97. 8.17 BLUE-EMU
  98. 8.17.1 BLUE-EMU Company Information
  99. 8.17.2 BLUE-EMU Business Overview
  100. 8.17.3 BLUE-EMU Transdermal Patch for Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BLUE-EMU Transdermal Patch for Pain Relief Product Portfolio
  102. 8.17.5 BLUE-EMU Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transdermal Patch for Pain Relief Value Chain Analysis
  2. 9.1.1 Transdermal Patch for Pain Relief Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transdermal Patch for Pain Relief Production Mode & Process
  6. 9.2 Transdermal Patch for Pain Relief Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transdermal Patch for Pain Relief Distributors
  9. 9.2.3 Transdermal Patch for Pain Relief Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst